Short Communication
Hong-Tao Wang
Abstract
Heart failure (HF) and arrhythmia often coexist and share the similar underlying pathogenesis, including autonomic imbalance, electrical remodeling, and inflammatory reactions. Low-level electrical stimulation (LL-ES) rebalances the tone of the autonomic nervous system and has an anti-arrhythmic effect. However, it is unknown whether LL-ES can decrease the inflammatory response and benefit patients suffering from both HF and arrhythmia. This study aimed to investigate the anti-arrhythmic and anti-inflammatory effects of LL-ES of aortic root ventricular ganglionated plexi (ARVGP). Twenty dogs were divided randomly into drug administration (control) and LL-ES groups after performing rapid right ventricle pacing to establish the HF model. The inducing rate of arrhythmia was measured after a programmed electrical procedure at the baseline and drug administration or LL-ES. The bioactive factors of HF, including angiotensin II, TGF-β, mitogen-activated protein kinase (MAPK), and matrix metalloproteinase (MMP), were assessed. Furthermore, ventricular size and left ventricular ejection fraction were determined. Compared with the control group, the inducing rate of arrhythmia decreased from 40% to 10% after 4 h of LL-ES (P < 0.05). The expression of angiotensin II, TGF-β, MAPK, and MMP was downregulated significantly in the LL-ES group (P < 0.05). Moreover, the volume of the left ventricle and the ejection fraction of the left ventricle in the LL-ES groupchanged little (P > 0.05). Short-term LL-ES of ARVGP presented both anti-arrhythmic and anti-inflammatory effects and contributed to the treatment of HF and the associated arrhythmia.